Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique

Infection and Immunity

Volumn 77, Issue 10, 2009, Pages 4502-4509

  Barbosa, Arnoldo ^a,b   Naniche, Denise ^b   Aponte, John J ^a,b   Manaca, M Nelia ^a   Mandomando, Inacio ^a,d   Aide, Pedro ^a,d   Sacarlal, Jahit ^c   Renom, Montse ^a,b   Lafuente, Sarah ^a,b   Ballou, W Ripley ^e   Alonso, Pedro L ^a,b  

^a Ministérioda Saúde   (Mozambique)

^b UNIVERSITY OF BARCELONA   (Spain)

^c EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^d INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CIRCUMSPOROZOITE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MALARIA VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDEMIC DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFANT; MALARIA FALCIPARUM; MOZAMBIQUE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPERNATANT;

ADULT; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALARIA VACCINES; MALARIA, FALCIPARUM; MOZAMBIQUE; PLACEBOS; PLASMODIUM FALCIPARUM; PREGNANCY; PROTOZOAN PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 70349416541     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00442-09     Document Type: Article

References (43)

1. Alheim, M., U. Lazdina, D. R. Milich, and M. Sallberg. 2001. Flow cytometric determination of cytokine production and proliferation in hepatitis B core antigen specific murine CD4 cells: lack of correlation between number of cytokine producing cells and cytokine levels in supernatant. J. Immunol. Methods 258:157-167. (Pubitemid 33016536)
2. Alonso, P. L., J. Sacarlal, J. J. Aponte, A. Leach, E. Macete, P. Aide, B. Sigauque, J. Milman, I. Mandomando, Q. Bassat, C. Guinovart, M. Espasa, S. Corachan, M. Lievens, M. M. Navia, M. C. Dubois, C. Menendez, F. Dubovsky, J. Cohen, R. Thompson, and W. R. Ballou. 2005. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 366:2012-2018.
3. Alonso, P. L., J. Sacarlal, J. J. Aponte, A. Leach, E. Macete, J. Milman, I. Mandomando, B. Spiessens, C. Guinovart, M. Espasa, Q. Bassat, P. Aide, O. Ofori-Anyinam, M. M. Navia, S. Corachan, M. Ceuppens, M. C. Dubois, M. A. Demoitie, F. Dubovsky, C. Menendez, N. Tornieporth, W. R. Ballou, R. Thompson, and J. Cohen. 2004. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364:1411-1420.
4. Aponte, J. J., P. Aide, M. Renom, I. Mandomando, Q. Bassat, J. Sacarlal, M. N. Manaca, S. Lafuente, A. Barbosa, A. Leach, M. Lievens, J. Vekemans, B. Sigauque, M. C. Dubois, M. A. Demoitie, M. Sillman, B. Savarese, J. G. McNeil, E. Macete, W. R. Ballou, J. Cohen, and P. L. Alonso. 2007. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 370:1543-1551.
5. Bojang, K. A., P. J. Milligan, M. Pinder, L. Vigneron, A. Alloueche, K. E. Kester, W. R. Ballou, D. J. Conway, W. H. Reece, P. Gothard, L. Yamuah, M. Delchambre, G. Voss, B. M. Greenwood, A. Hill, K. P. McAdam, N. Tornieporth, J. D. Cohen, and T. Doherty. 2001. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358:1927-1934.
6. Bojang, K. A., F. Olodude, M. Pinder, O. Ofori-Anyinam, L. Vigneron, S. Fitzpatrick, F. Njie, A. Kassanga, A. Leach, J. Milman, R. Rabinovich, K. P. McAdam, K. E. Kester, D. G. Heppner, J. D. Cohen, N. Tornieporth, and P. J. Milligan. 2005. Safety and immunogenicity of RTS,S/AS02A candidate malaria vaccine in Gambian children. Vaccine 23:4148-4157. (Pubitemid 40814590)
7. Chatterjee, S., M. Wery, P. Sharma, and V. S. Chauhan. 1995. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge. Infect. Immun. 63:4375-4381.
8. Chelimo, K., P. O. Sumba, J. W. Kazura, A. V. Ofula, and C. C. John. 2003. Interferon-gamma responses to Plasmodium falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria holoendemic area of western Kenya. Malaria J. 2:37.
9. Clyde, D. F., V. C. McCarthy, R. M. Miller, and R. B. Hornick. 1973. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266:398-403.
10. Dame, J. B., J. L. Williams, T. F. McCutchan, J. L. Weber, R. A. Wirtz, W. T. Hockmeyer, W. L. Maloy, J. D. Haynes, I. Schneider, D. Roberts, et al. 1984. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225:593-599. (Pubitemid 14053761)
11. Doolan, D. L., R. A. Houghten, and M. F. Good. 1991. Location of human cytotoxic T-cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. Int. Immunol. 3:511-516.
12. Engers, H. D., and T. Godal. 1998. Malaria vaccine development: current status. Parasitol. Today 14:56-64. (Pubitemid 28055412)
13. Good, M. F., L. H. Miller, S. Kumar, I. A. Quakyi, D. Keister, J. H. Adams, B. Moss, J. A. Berzofsky, and R. Carter. 1988. Limited immunological recognition of critical malaria vaccine candidate antigens. Science 242:574-577.
14. Greenwood, B., and T. Mutabingwa. 2002. Malaria in 2002. Nature 415:670-672.
15. Hanekom, W. A., J. Hughes, M. Mavinkurve, M. Mendillo, M. Watkins, H. Gamieldien, S. J. Gelderbloem, M. Sidibana, N. Mansoor, V. Davids, R. A. Murray, A. Hawkridge, P. A. Haslett, S. Ress, G. D. Hussey, and G. Kaplan. 2004. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J. Immunol. Methods 291:185-195.
16. Heppner, D. G., Jr., K. E. Kester, C. F. Ockenhouse, N. Tornieporth, O. Ofori, J. A. Lyon, V. A. Stewart, P. Dubois, D. E. Lanar, U. Krzych, P. Moris, E. Angov, J. F. Cummings, A. Leach, B. T. Hall, S. Dutta, R. Schwenk, C. Hillier, A. Barbosa, L. A. Ware, L. Nair, C. A. Darko, M. R. Withers, B. Ogutu, M. E. Polhemus, M. Fukuda, S. Pichyangkul, M. Gettyacamin, C. Diggs, L. Soisson, J. Milman, M. C. Dubois, N. Garcon, K. Tucker, J. Wittes, C. V. Plowe, M. A. Thera, O. K. Duombo, M. G. Pau, J. Goudsmit, W. R. Ballou, and J. Cohen. 2005. Towards an RTS,S-based, multi-stage, multiantigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine 23:2243-2250.
17. Hoffman, S. L., L. M. Goh, T. C. Luke, I. Schneider, T. P. Le, D. L. Doolan, J. Sacci, P. de la Vega, M. Dowler, C. Paul, D. M. Gordon, J. A. Stoute, L. W. Church, M. Sedegah, D. G. Heppner, W. R. Ballou, and T. L. Richie. 2002. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185:1155-1164.
18. Kassu, A., A. Tsegaye, B. Petros, D. Wolday, E. Hailu, T. Tilahun, B. Hailu, M. T. Roos, A. L. Fontanet, D. Hamann, and T. F. De Wit. 2001. Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales. Clin. Diagn. Lab. Immunol. 8:1171-1176.
19. Kester, K. E., J. F. Cummings, C. F. Ockenhouse, R. Nielsen, B. T. Hall, D. M. Gordon, R. J. Schwenk, U. Krzych, C. A. Holland, G. Richmond, M. G. Dowler, J. Williams, R. A. Wirtz, N. Tornieporth, L. Vigneron, M. Delchambre, M. A. Demoitie, W. R. Ballou, J. Cohen, and D. G. Heppner, Jr. 2008. Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research. Vaccine 26:2191-2202.
20. Kester, K. E., D. A. McKinney, N. Tornieporth, C. F. Ockenhouse, D. G. Heppner, T. Hall, U. Krzych, M. Delchambre, G. Voss, M. G. Dowler, J. Palensky, J. Wittes, J. Cohen, and W. R. Ballou. 2001. Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J. Infect. Dis. 183:640-647.
21. Kester, K. E., D. A. McKinney, N. Tornieporth, C. F. Ockenhouse, D. G. Heppner, Jr., T. Hall, B. T. Wellde, K. White, P. Sun, R. Schwenk, U. Krzych, M. Delchambre, G. Voss, M. C. Dubois, R. A. Gasser, Jr., M. G. Dowler, M. O'Brien, J. Wittes, R. Wirtz, J. Cohen, and W. R. Ballou. 2007. A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adults. Vaccine 25:5359-5366.
22. Lalvani, A., P. Moris, G. Voss, A. A. Pathan, K. E. Kester, R. Brookes, E. Lee, M. Koutsoukos, M. Plebanski, M. Delchambre, K. L. Flanagan, C. Carton, M. Slaoui, C. Van Hoecke, W. R. Ballou, A. V. Hill, and J. Cohen. 1999. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J. Infect. Dis. 180:1656-1664.
23. Macete, E., J. J. Aponte, C. Guinovart, J. Sacarlal, O. Ofori-Anyinam, I. Mandomando, M. Espasa, C. Bevilacqua, A. Leach, M. C. Dubois, D. G. Heppner, L. Tello, J. Milman, J. Cohen, F. Dubovsky, N. Tornieporth, R. Thompson, and P. L. Alonso. 2007. Safety and immunogenicity of the RTS,S/ AS02A candidate malaria vaccine in children aged 1-4 in Mozambique. Trop. Med. Int. Health 12:37-46.
24. Macete, E. V., J. Sacarlal, J. J. Aponte, A. Leach, M. M. Navia, J. Milman, C. Guinovart, I. Mandomando, Y. Lopez-Pua, M. Lievens, A. Owusu-Ofori, M. C. Dubois, C. P. Cahill, M. Koutsoukos, M. Sillman, R. Thompson, F. Dubovsky, W. R. Ballou, J. Cohen, and P. L. Alonso. 2007. Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial. Trials 8:11.
25. Malkin, E., F. Dubovsky, and M. Moree. 2006. Progress toward the development of malaria vaccines. Trends Parasitol. 22:292-295. (Pubitemid 43946705)
26. Matuschewski, K., and A. K. Mueller. 2007. Vaccines against malaria: an update. FEBS J. 274:4680-4687.
27. Moorthy, V. S., M. F. Good, and A. V. Hill. 2004. Malaria vaccine developments. Lancet 363:150-156.
28. Nardin, E., Y. D. Munesinghe, A. Moreno, P. Clavijo, M. C. Calle, R. Edelman, J. Davis, D. Herrington, and R. S. Nussenzweig. 1992. T-cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites. Mem. Inst. Oswaldo Cruz 87(Suppl. 3):223-227.
29. Nussenzweig, R. S., and F. Zavala. 1997. A malaria vaccine based on a sporozoite antigen. N. Engl. J. Med. 336:128-130.
30. Pinder, M., W. H. Reece, M. Plebanski, P. Akinwunmi, K. L. Flanagan, E. A. Lee, T. Doherty, P. Milligan, A. Jaye, N. Tornieporth, R. Ballou, K. P. McAdam, J. Cohen, and A. V. Hill. 2004. Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semiimmune adults in The Gambia. Clin. Exp. Immunol. 135:286-293.
31. + T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat. Med. 10: 406-410.
32. Reed, G. F., B. D. Meade, and M. C. Steinhoff. 1995. The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data. Pediatrics 96:600-603.
33. Saathoff, E., P. Schneider, V. Kleinfeldt, S. Geis, D. Haule, L. Maboko, E. Samky, M. de Souza, M. Robb, and M. Hoelscher. 2008. Laboratory reference values for healthy adults from southern Tanzania. Trop. Med. Int. Health 13:612-625.
34. Sacarlal, J., J. J. Aponte, P. Aide, I. Mandomando, Q. Bassat, C. Guinovart, A. Leach, J. Milman, E. Macete, M. Espasa, O. Ofori-Anyinam, J. Thonnard, S. Corachan, M. C. Dubois, M. Lievens, F. Dubovsky, W. R. Ballou, J. Cohen, and P. L. Alonso. 2008. Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial. Vaccine 26:174-184. (Pubitemid 50008836)
35. Sedegah, M., M. Belmonte, J. E. Epstein, C. A. Siegrist, W. R. Weiss, T. R. Jones, M. Lu, D. J. Carucci, and S. L. Hoffman. 2003. Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers. J. Immunol. 171:3148-3153. (Pubitemid 37093539)
36. Siegrist, C. A. 2000. Vaccination in the neonatal period and early infancy. Int. Rev. Immunol. 19:195-219.
37. Snow, R. W., C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214-217.
38. Ssewanyana, I., C. Pietras, C. A. Baker, F. Nghania, N. G. Jones, P. J. Rosenthal, G. Dorsey, and H. Cao. 2008. Pattern of malaria-specific T-cell responses in a cohort of Ugandan children. J. Trop. Pediatr. 54:6-13.
39. Stewart, V. A., S. M. McGrath, P. M. Dubois, M. G. Pau, P. Mettens, J. Shott, M. Cobb, J. R. Burge, D. Larson, L. A. Ware, M. A. Demoitie, G. J. Weverling, B. Bayat, J. H. Custers, M. C. Dubois, J. Cohen, J. Goudsmit, and D. G. Heppner, Jr. 2007. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone. Infect. Immun. 75:2283-2290.
40. Stoute, J. A., K. E. Kester, U. Krzych, B. T. Wellde, T. Hall, K. White, G. Glenn, C. F. Ockenhouse, N. Garcon, R. Schwenk, D. E. Lanar, P. Sun, P. Momin, R. A. Wirtz, C. Golenda, M. Slaoui, G. Wortmann, C. Holland, M. Dowler, J. Cohen, and W. R. Ballou. 1998. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J. Infect. Dis. 178:1139-1144.
41. Stoute, J. A., M. Slaoui, D. G. Heppner, P. Momin, K. E. Kester, P. Desmons, B. T. Wellde, N. Garcon, U. Krzych, M. Marchand, et al. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N. Engl. J. Med. 336:86-91.
42. + T cells producing IFN-gamma. J. Immunol. 171:6961-6967.
43. Tsegaye, A., D. Wolday, S. Otto, B. Petros, T. Assefa, T. Alebachew, E. Hailu, F. Adugna, W. Measho, W. Dorigo, A. L. Fontanet, D. van Baarle, and F. Miedema. 2003. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clin. Immunol. 109:338-346.